← Evidence map

ReviewClinical pharmacokinetics2001

Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding.

T R Perry et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2001
…
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 11605716